You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EpCAM

Showing 1 - 25 of 125
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Infiltrating Duct Carcinoma of the Breast

Not yet recruiting
  • Invasive Breast Cancer
    • (no location specified)
    Jan 28, 2023

    Epithelial Cell Adhesion Molecule in Epithelial Ovarian

    Recruiting
    • Ovarian Carcinoma
      • Sohag, Egypt
      • +1 more
      Oct 8, 2022

      Solid Tumor, Adult Trial in Tomsk (Diagnostic Test: whole body study and SPECT with [99mTc]Tc(CO)3-(HE)3-Ec1)

      Enrolling by invitation
      • Solid Tumor, Adult
      • Diagnostic Test: whole body study and SPECT with [99mTc]Tc(CO)3-(HE)3-Ec1
      • Tomsk, Russian Federation
        TomskNRMC
      Jan 23, 2023

      Recurrent or Metastatic Solid Tumors Trial (Recombinant Anti-EpCAM-CD3 Antibody Injection)

      Not yet recruiting
      • Recurrent or Metastatic Solid Tumors
      • Recombinant Anti-EpCAM-CD3 Antibody Injection
      • (no location specified)
      Oct 17, 2023

      Advanced Hepatocellular Carcinoma, Advanced Colorectal Cancer, Advanced Gastric Cancer Trial in Hangzhou (EPCAM CAR-T)

      Recruiting
      • Advanced Hepatocellular Carcinoma
      • +3 more
      • EPCAM CAR-T
      • Hangzhou, China
        First affiliated hospital, School of Medicine, Zhejiang Universi
      Jan 12, 2022

      Advanced Adenocarcinoma Trial (BA3182)

      Not yet recruiting
      • Advanced Adenocarcinoma
      • (no location specified)
      Apr 10, 2023

      Urinary Bladder Tumors Trial in München (Catumaxomab)

      Recruiting
      • Urinary Bladder Neoplasms
      • München, Germany
        Urologie Planegg
      Apr 4, 2022

      Malignant Pleural Effusions, NSCLC Stage IV Trial in Hangzhou (M701 pleural infusion, Pleural drainage, Cisplatin pleural

      Not yet recruiting
      • Malignant Pleural Effusions
      • NSCLC Stage IV
      • M701 pleural infusion
      • +2 more
      • Hangzhou, Zhejiang, China
        Cancer Hospital of the University of Chinese Academy of Sciences
      Sep 14, 2022

      Lung Cancer, Surgery, Circulating Tumor Cell Trial in Amsterdam, Leiden (Cetuximab)

      Not yet recruiting
      • Lung Cancer
      • +2 more
      • Amsterdam, Netherlands
      • +1 more
      Oct 19, 2021

      Cascade Testing in Families With Newly Diagnosed Hereditary

      Recruiting
      • BRCA-Mutated Ovarian Carcinoma
      • +7 more
      • CASCADE genetic screening
      • New York, New York
        NYU Langone Health
      Apr 30, 2021

      An Intervention to Increase Genetic Testing in Families Who May

      Recruiting
      • BRCA1 Mutation
      • +21 more
      • Intervention Arm At-risk Relative/ARR Contacts
      • +5 more
      • Basking Ridge, New Jersey
      • +7 more
      Nov 22, 2022

      Deleterious BARD1 Gene Mutation, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation Trial in United States

      Active, not recruiting
      • Deleterious BARD1 Gene Mutation
      • +13 more
      • Laboratory Biomarker Analysis
      • +4 more
      • Chicago, Illinois
      • +8 more
      Feb 25, 2022

      Determination of Blood Tumor Cells

      Completed
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • Abnormalities Cell Epithelial
        • Zurich, Switzerland
          University Hospital Zurich
        Jan 9, 2023

        Advanced Solid Tumor, Tumors Trial (TM4SF1- and EpCAM-positive chimeric antigen receptor T-cell therapy)

        Unknown status
        • Advanced Solid Tumor
        • Neoplasms
        • TM4SF1- and EpCAM-positive chimeric antigen receptor T-cell therapy
        • (no location specified)
        Nov 1, 2019

        Clinical Significance of Circulating Tumour Cells in Resectable

        Completed
        • Non Small Cell Lung Cancer
        • Circulating Tumor Cell
        • Device for CTC/DTC detection
        • Olomouc, Česká Republika, Czechia
          University Hospital Olomouc
        Nov 9, 2022

        Urinary Bladder Tumors Trial run by the NCI (Durvalumab, Vicineum)

        Recruiting
        • Urinary Bladder Neoplasms
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Feb 2, 2023

        Melanoma Stage IV, Sarcoma, Squamous Cell Carcinoma Trial in Berlin (CTC isolation by HSP70)

        Recruiting
        • Melanoma Stage IV
        • +5 more
        • CTC isolation by HSP70
        • Berlin, Germany
          Klinik für Radioonkologie und Strahlentherapie
        May 12, 2021

        Lynch Syndrome, Lynch Syndrome I, Lynch Syndrome II Trial in Milan (Video capsule endoscopy)

        Recruiting
        • Lynch Syndrome
        • +7 more
        • Video capsule endoscopy
        • Milan, Lombardia, Italy
          San Raffaele Scientific Institute, Gastroenterology and Gastroin
        Jan 27, 2023

        Advanced Liver Cancer Trial in Beijing (Activated CIK, CIK)

        Recruiting
        • Advanced Liver Cancer
        • Activated CIK
        • CIK
        • Beijing, Beijing, China
          302 Military Hospital of China
        Jan 27, 2021

        Colorectal Cancer, Lynch Syndrome, Hereditary Colorectal Cancer Trial in Moscow

        Not yet recruiting
        • Colorectal Cancer
        • +3 more
          • Moscow, Russian Federation
            State Scientific Centre of Coloproctology
          Aug 8, 2022

          Precision-Based Genomics in Prostate Cancer

          Recruiting
          • Prostate Cancer
            • La Jolla, California
            • +4 more
            Jul 28, 2022

            Unveiling the Microbial Impact on Intestinal Fibrosis

            Not yet recruiting
            • Crohn Disease
            • Surgical specimens of CD and no-IBD patients
            • Milan, Italy
              IRCCS Ospedale San Raffaele
            Oct 2, 2023

            Meningeal Carcinomatosis Trial in Amsterdam (lumbar puncture)

            Completed
            • Meningeal Carcinomatosis
            • lumbar puncture
            • Amsterdam, Netherlands
            • +1 more
            Jan 19, 2021

            Altered Transcriptomic and Immune Accompanied by Identification

            Recruiting
            • Breast Cancer Patients
            • surgery for breast cancer and imaging test evaluations
            • Naples, Italy
              IRCCS Synlab SDN
            Mar 29, 2023

            Tumor Malignant Trial in Napoli (CLG)

            Active, not recruiting
            • Neoplasm Malignant
            • CLG
            • Napoli, Italy
            • +1 more
            Apr 18, 2023